Shyam Reddy is an internationally known cancer researcher who has discovered and studied nearly 20 cancer genes (www.reddyesp.com). The most notable genes discovered by Dr. Reddy include ETS-related gene (ERG): ERG-1, ERG-2, ERG-3, and human FLI-1 genes. ERG has been shown to be involved in the majority of prostate cancers. It is also involved in Ewing sarcoma and acute myeloid leukemia. Dr. Reddy's laboratory is currently targeting these oncoproteins for their functions in order to develop new targeted therapeutic agents. Dr. Reddy received several RO1, ACS, DOD, and GCC grants to carry out this work. He received several personal awards that include Bharat Gaurav Award for Excellence in Science, GCC Distinguished Cancer Scholar award, TAMA award for excellence in science and medicine, ATA award for Excellence in Science, Dean's Recognition Award for Research, Morehouse School of Medicine, and Swebelius Cancer Research Award at Yale University. Dr. Reddy received his Ph.D. degree from the CCMB in Hyderabad, India. He published back-to-back papers in nature and won the National Young Scientist Award for his graduate research. He received postdoctoral training at Yale University in New Haven, Conn. Dr. Reddy's professional affiliations include a Staff Scientist at the National Cancer Institute at the Frederick, MD branch, an Assistant Professor at the Wistar Institute and an Associate Professor at the Temple University and Thomas Jefferson University, both in Philadelphia, Pa, and a Professor and Director of the Division of Cancer Genetics at MCP Hahnemann University and Drexel University in Philadelphia. He is presently working as a Professor and Codirector of the Cancer Biology Program, Department of Obstetrics & Gynecology, Morehouse School of Medicine, Atlanta, Ga, USA.
Biography Updated on 17 October 2011